SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000950123-11-083977
Filing Date
2011-09-12
Accepted
2011-09-12 15:44:21
Documents
6
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A c22116e10vqza.htm 10-Q/A 19085
  Complete submission text file 0000950123-11-083977.txt   1262807

Data Files

Seq Description Document Type Size
2 EX-101 INSTANCE DOCUMENT ljpc-20110630.xml EX-101.INS 214579
3 EX-101 SCHEMA DOCUMENT ljpc-20110630.xsd EX-101.SCH 10474
4 EX-101 CALCULATION LINKBASE DOCUMENT ljpc-20110630_cal.xml EX-101.CAL 19942
5 EX-101 LABELS LINKBASE DOCUMENT ljpc-20110630_lab.xml EX-101.LAB 88600
6 EX-101 PRESENTATION LINKBASE DOCUMENT ljpc-20110630_pre.xml EX-101.PRE 54318
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-24274 | Film No.: 111085739
SIC: 2836 Biological Products, (No Diagnostic Substances)